Abstract
AbstractQuetiapine prolonged release (Seroquel XL) now has a licence extension as an addon treatment of major depressive episodes in patients with major depressive disorder. Dr Sameer Jauhar presents the clinical data relating to its efficacy and adverse effects and discusses its place in treatment. Copyright © 2011 Wiley Interface Ltd
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
